P. Buckel – Recombinant Protein Drugs

Recombinant protein drugs are intimately associated with the impressive success story of the biotech industry during the past 30 years, some of them belonging to the most successful pharmaceutical products. More than 30 different proteins are available for a variety of clinical applications, over 300 proteins are presently being evaluated in clinical trials. In this new volume of the MDT series, historical, technical and clinical aspects of recombinant protein drug discovery and development are